Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 2/5/2026CDE Issues Trial Guideline for Neuropathic Pain Drug Development
  • 2/5/2026CDE Issues Technical Guideline for Clinical Trials of Chronic Insomnia...
  • 2/4/2026Innovent Advances IL-15 Antibody IBI3013 Into Clinical Trials for Viti...
  • 2/4/2026China Clears BeBetter Med Dual-Target siRNA Therapy for Combined Hyper...
  • 2/4/2026Vertex Takes Global Control of WuXi Biologics Trispecific T-Cell Engag...
  • 2/4/2026Novartis Secures Global Rights to SciNeuro’s Next-Gen Alzheimer’s An...
  • 2/4/2026Chia Tai Tianqing's Anlotinib New Indication Application Rejected
  • 2/4/2026China Gene‑Editing Startup AccurEdit Raises $75M to Advance Promising...
  • 2/4/2026WuXi Biologics and Sinorda Join Forces to Develop Bispecific Antibody ...
  • 2/4/2026Almirall's Seysara Approved in China for Moderate-to-Severe Acne
  • 2/4/2026Ant Group's AI Health Chatbot Surges in Popularity Amid China's Overbu...
  • 2/4/2026China's Health Insurance Market Poised for $596B Surge by 2033
  • 2/4/2026Bayer's Nubeqa Gains Third Approval in China for Advanced Prostate Can...
  • 2/4/2026CMS Gets Green Light from NMPA to Launch Trials for Novel Kidney Disea...
  • 2/3/2026NMPA Logs Wave of Novel Drug Approvals and Clinical Trial Clearances L...
  • 2/3/2026Beijing-Based PrimeGenX Therapeutics' HKSE IPO Application Accepted
  • 2/3/2026HSG Completes Global Acquisition of Avelox and Launches Anti-Infective...
  • 2/3/2026New Indication for Novartis' Secukinumab in Non-Radiographic Axial Spo...
  • 2/3/2026Zonsen PepLib Signs Global Peptide R&D Deal with Eli Lilly
  • 2/3/2026Siran Bio Advances Global Clinical Development of ALK7 siRNA SA030
  • 2/3/2026Hengrui's Camrelizumab Combo Accepted by FDA for First-Line Liver Canc...
  • 2/3/2026Zhiben Wins China IND Approval for AR Molecular Glue Degrader ZB-002 i...
  • 2/3/2026Newsoara Expands Global Footprint With $135M Deal for vTv's Inflammati...
  • 2/3/2026China and USFDA Officials Pledge to Deepen Regulatory Cooperation at B...
  • 2/3/2026China Tightens BMI Fund Oversight for 2026 With Nationwide Crackdown o...
  • 2/3/2026Zenshine Files for Hong Kong IPO to Fuel Expansion Across Infectious D...
  • 2/3/2026SanegeneBio Strikes Global RNAi Licensing Deal With Genentech Worth Up...
  • 1/31/2026Recent Official and Executive Moves
  • 1/31/2026China's Vaccine Exports Jump More Than 50% in 2025 as Overseas Shipmen...
  • 1/30/2026China's Basic Medical Insurance Fund Posts Solid Surplus in 2025 as In...
  • Page:15/62 Total number of articles:1845: [First][<<] [13] [14] [15] [16] [17] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group